ALX Oncology (ALXO) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

6

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.94

Median Target+106.19%

$4.00

Potential upside vs current price

DCF Value-93.40%

$0.13

Potential downside vs current price

Current Stock Price

$1.94

Median Target+106.19%

$4.00

Potential upside vs current price

DCF Value-93.40%

$0.13

Potential downside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

6

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.94

Median Target+106.19%

$4.00

Potential upside vs current price

DCF Value-93.40%

$0.13

Potential downside vs current price

Current Stock Price

$1.94

Median Target+106.19%

$4.00

Potential upside vs current price

DCF Value-93.40%

$0.13

Potential downside vs current price

ALX Oncology Holdings Inc.